A novel immunoglobulin G monolayer silver bio-nanocomposite by unknown
Matea et al. Chemistry Central Journal  (2015) 9:55 
DOI 10.1186/s13065-015-0126-z
RESEARCH ARTICLE
A novel immunoglobulin G monolayer 
silver bio-nanocomposite
Cristian T. Matea1, Teodora Mocan1,2, Florin Zaharie1, Cornel Iancu1 and Lucian Mocan1*
Abstract 
Background: Nanoparticles have a large number of surface atoms, which translates into a significant increase in the 
surface energy. Once introduced in a biological environment they tend to interact with proteins and form a protein 
corona shell. The aim of this study was to develop a novel, silver based, bio-nanocomposite for biological applications. 
Immunoglobulin G (IgG) molecule was chosen for the passivation of the silver nanoparticles (AgNPs) in order to avoid 
macrophage recognition of the synthesized structures.
Results: Monodisperse IgG-folinate functionalized silver nanoparticles were obtained, with sizes around 39 nm. UV–
Vis and UATR-FT-IR spectroscopies were employed to confirm the successful functionalization of the silver nanoparti-
cles. Atomic force microscopy and dynamic light scattering measurements gave information about the size and shape 
of the nanoparticles prior and after the passivation with IgG.
Conclusions: Immunoglobulin G formed a monolayer around the nanoparticles with the binding site seemingly in 
the Fc domain, leaving the two Fab regions available for antigen binding. To our knowledge, this is the first report of 
an IgG-folinate functionalized AgNP bionanostructure developed for biological applications.
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Background
In the past few decades, metal nanoparticles have been 
developed for a variety of applications, such as biosen-
sors, anti-bacterial agents, drug-delivery vehicles, con-
trast agents and so on. Silver nanoparticles (AgNPs) have 
attracted a lot of attention due to their ease of synthesis, 
chemical stability, good conductivity and antimicrobial 
properties [1–3].
A wide variety of methods for silver nanoparticle syn-
thesis is available in literature, these include: chemical 
reduction, laser ablation, thermal decomposition and 
sonochemical synthesis [4–8]. A vastly utilized method 
for silver nanoparticle synthesis is the reduction of sil-
ver ions in a aqueous solution in the presence of a cap-
ping agent [9], such as citrate molecules which impart 
negative surface charges that prevent nanoparticle aggre-
gation through repulsion forces [10].
Silver nanoparticles present a surface plasmon reso-
nance band (SPR) derived from the collective oscillation 
of valence electrons under stimulation from incident 
light, this phenomenon is observed when the frequency 
of light photons matches the natural frequency of surface 
electrons oscillating against the restoring force [11]. The 
SPR band is sensitive to the nanoparticle size and shape 
and also to the properties of the surrounding medium 
[12].
Nanoparticles have a large number of surface atoms, 
which translates into a significant increase in the surface 
energy. A tendency to reduce their large surface energy 
by interacting with the surrounding components that 
contain donating or accepting sites has been observed 
[13]. Literature data shows that nanoparticles introduced 
in a biological environment tend to interact with proteins 
and form a protein corona shell [14]. The nature of the 
protein corona influences the extent and mechanism of 
nanoparticle cellular internalization [15, 16]. AgNPs that 
are stable enough to significantly restrict bacterial growth 
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are challenging to prepare [17]. Thus, the passivation of 
nanoparticles, a technique that involves surface modi-
fication or coating with naturally-occurring molecules 
(such as serum abundant proteins or fatty acids) has to be 
taken into account when designing nanoparticles for life 
sciences applications [18, 19].
It has been showed that when the protein concentra-
tion is sufficient to cover the available silver nanoparticle 
surface, the protein molecules at the metal–water inter-
face retain their native structure [20].
Silver has a well-documented toxic effect on lower 
organisms while a biological role in the human body 
has not yet been demonstrated [21]. Aueviriyavit et  al. 
showed that AgNPs can cause acute cellular damage in 
Caco-2 (HTB-37) cells but only after treatment with rela-
tively high amounts nanoparticles [22]. Several other 
studies show that AgNPs can cause apoptosis, DNA dam-
age or cause oxidative stress, but interestingly toxicity 
levels reported vary greatly [17]. Thus, the AgNPs low 
toxicity in humans makes them excellent candidates for 
future silver based drugs in the fight against antibiotic-
resistant bacteria [21]. Strong antibacterial activity of 
AgNPs was demonstrated at very low total concentra-
tions of silver (<7  ppm) against several Gram-positive 
and Gram-negative bacteria. The exact mechanism 
through which they present antimicrobial properties is 
yet to be elucidated [23].
Nanoparticles, due to their size, shape and surface 
chemistry are prone to interception by different defence 
components following entry into the body. For mac-
rophage avoidance of nanoparticles several strategies that 
suppress the opsonisation processes can be undertaken. 
Thus, nanoparticle surface modification or coating with 
natural occurring complement inhibitors yield stealth or 
macrophage-avoiding nanoparticles [18].
Immunoglobulin G (IgG) is composed of four poly-
peptidic chains, two heavy and two light chains, linked 
through a disulphidic bond to give a ‘Y-shaped’ confor-
mation. IgG has one Fc domain, which should be pre-
ferred in the adsorption onto the nanoparticle surface 
and two identical Fab domains responsible for antigen 
binding [24].
Calcium folinate (CF) is the salt form of folinic acid, 
a known drug used to combat the adverse effects of tet-
rahydrofolate reductase inhibitors [25].
The aim of this study was to develop a novel, sil-
ver based, bio-nanocomposite for biological applica-
tions. IgG molecule was chosen for the passivation 
of the AgNPs in order to avoid macrophage recogni-
tion of the synthesized structures. To our knowledge, 
this is the first report of an IgG-folinate functional-
ized AgNP bionanostructure developed for biological 
applications.
Results and discussions
The synthesis protocol used for obtaining the AgNP–
IgG–CF bio-nanocomposite is presented in Fig.  1 and 
has three stages: in the first stage silver ions (Ag+) were 
reduced to metallic silver (Ag0) with the aid of sodium 
citrate; in the second stage IgG molecules were covalently 
coupled to the CF molecules and in the third stage sil-
ver nanoparticles were functionalized with the IgG–CF 
conjugate. The obtained functionalized nanoparticles in 
aqueous solution were kept at both room temperature 
(20 °C) and 4 °C for several weeks and did not present any 
agglomeration or sedimentation.
Fig. 1 Graphical illustration of the synthesis protocol for the AgNP–IgG–CF bio-nanocomposite
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UV–Vis spectroscopy is a valuable technique in terms 
of size and morphology characterization of silver nano-
particle dispersions [26]. The UV–Vis spectra for the 
AgNP, IgG, IgG–CF and AgNP–IgG–CF samples are pre-
sented in Fig.  2. The citrate capped silver nanoparticles 
presented a surface plasmon resonance band (SPR) at 
433 nm [27], while the IgG and the IgG–CF conjugate had 
a λmax centered at 284 nm. In the case of AgNP–IgG–CF 
bio-nanocomposite the UV–Vis spectra two absorbtion 
peaks can be observed. The first peak, situated at 432 nm, 
is attributed to the SPR band of silver nanoparticles [28–
30], while the second peak, at 284 nm, is attributed to the 
IgG molecules [31] coupled to the surface of AgNPs in 
the functionalization step. Available literature data shows 
that the SPR profile of AgNPs is dependent to the protein 
concentration and the surrounding media [20].
Dynamic light scattering (DLS) measurements were 
performed in order to investigate the size of the citrate 
capped silver nanoparticles and IgG–CF functionalized 
AgNP. The DLS size distribution curves for the hydrody-
namic diameters of AgNP and AgNP–IgG–CF samples 
are presented in Fig.  3. Both samples presented them-
selves as being monodisperse and stable at room tem-
perature. For the AgNP a mean diameter of ~29 nm was 
registered, while the AgNP–IgG–CF had a mean hydro-
dynamic diameter of ~48  nm. The polydispersity index 
for the AgNP–IgG–CF sample was 0.283, indicating a 
narrow size range.
The typical dimensions reported in literature for IgG 
are approximately 14.5  nm ×  8.5  nm ×  4  nm [32], this 
corroborated with the DLS data, suggests that IgG has 
formed a monolayer on the surface of AgNPs during the 
functionalization step. Also the binding site of the immu-
noglobulin to the silver nanoparticle surface seems to be 
in the Fc domain, leaving the two Fab regions available 
for antigen binding.
Attenuated total reflectance Fourier transform infra-
red (ATR-FT-IR) spectroscopy is a straightforward 
technique that gives valuable information about the sec-
ondary structure of proteins [31]. Figure  4 depicts the 
IR spectra of (A) calcium folinate, (B) immunoglobu-
lin G, (C) IgG–CF functionalized silver nanoparticles, 
(D) citrate capped silver nanoparticles and (E) IgG–CF 
conjugate. Figure  4f shows a comparison, in the 2500–
1000  cm−1 region, between the IR spectra presented in 
Fig. 4a–e. In the case of the AgNP sample, the absorbtion 
Fig. 2 UV–Vis spectra for AgNP, IgG, IgG–CF and AgNP–IgG–CF 
samples
Fig. 3 Dynamic light scattering size distribution curves for AgNP (red) and AgNP–IgG–CF (green) samples
Page 4 of 7Matea et al. Chemistry Central Journal  (2015) 9:55 
bands at 1590 and 1370  cm−1 are attributed to the 
antisymmetric and, respectively symmetric stretching 
vibrations of COO− from citrate molecule present on the 
surface of silver nanoparticles [33, 34]. For the IgG and 
IgG–CF samples, the IR bands at 1635–1638 and 1534–
1554 cm−1 correspond to the amide I band (which leads 
to stretching vibrations of the C=O bond of the amide) 
and, respectively to the amide II band (C–N stretching 
and N–H bending vibrations) from the IgG β-sheets [31, 
35]. These absorption bands are also present in the final 
bio-nanocomposite at 1637 and 1534  cm−1, making the 
IR spectra of the IgG and AgNP–IgG–CF nearly identi-
cal. Thus, in the case of the AgNP–IgG–CF sample, the 
disappearance of the IR band attributed to citrate ions, 
corroborated with the appearance of IgG characteristic 
IR bands confirm the successful functionalization of sil-
ver nanoparticles with the IgG–CF conjugate.
Atomic force microscopy was conducted in order to 
further investigate the size and shape of the AgNP–IgG–
CF bio-nanocomposite. Figure 5a is a 2D representation 
of a single AgNP–IgG–CF nanoparticle, while Fig.  5c 
is a 3D representation of the same bio-nanostructure. 
AFM data collected showed that AgNPs were spherical 
in shape and had a mean diameter of ~26 nm. The IgG–
CF functionalized silver nanoparticles were ~39  nm in 
diameter. The difference between the DLS and AFM data 
regarding nanoparticle size can be attributed to the fact 
that the dynamic light scattering technique provides a 
hydrodynamic diameter of the nanoparticle and the asso-
ciated solvation layers [36].
Experimental
Silver nitrate (AgNO3 99.9  %), sodium citrate (≥99  %), 
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC) and N-Hydroxysuccinimide (NHS) 
were purchased from Sigma-Aldrich™ (Darmstadt, 
Germany) and were used without further purification. 
Immunoglobulin G (IgG) was purchased from Kedrion 
(Lucca, Italy) and was purified with the aid of Pierce® 
centrifugal concentrators with a 30 kDa molecular weight 
Fig. 4 ATR-FT-IR spectra for: a CF; b IgG; c AgNP–IgG–CF; d AgNP; e IgG–CF samples in the region 4000–450 cm−1; and f comparison between the 
samples in the 2500–1000 cm−1 region
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cut-off. Calcium folinate (CF) was purchased from Act-
avis (Romania). All glassware used was cleaned with aqua 
regia (HCl:HNO3, 3:1) prior to use.
Aqueous stable silver nanoparticles (AgNPs) were 
obtained by reducing silver ions in the presence of 
sodium citrate. Thus, 9  mg AgNO3 were dissolved in 
Fig. 5 AFM measurement of AgNP–IgG–CF: a 2D image (scale bar 200 nm); b cross section graph of a single AgNP-IgG-CF nanoparticle; c 3D 
rendering of AgNP–IgG–CF
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50 mL H2O dist. and the solution was heated to boiling 
point. Next, 2 mL of sodium citrate (0.5 %) were quickly 
added under vigorous stirring and the reaction was 
allowed to continue until the solution reached a pale-yel-
low colour.
In order to covalently bind the immunoglobulin G 
with the calcium folinate, 3 mL IgG solution (5 mg/mL) 
were reacted with 1.5 mL EDC solution (30 mg/mL) and 
1.5 mL NHS sol. (30 mg/mL) under continuous stirring 
for 20  min, at room temperature. Afterwards, 1  mL CF 
(3  mg/mL) was added and the reaction allowed to con-
tinue for another 30 min. For the purification of the IgG–
CF conjugate, centrifugal concentrators with a molecular 
cut-off of 30 kDa were used at 4000 RPM for 60 min. The 
purified IgG–CF was re-eluted in 6  mL H2O dist. and 
4 mL AgNP sol. were added under vigorous stirring, the 
reaction was allowed to continue at room temperature 
for 60  min. Finally, the obtained AgNP–IgG–CF bio-
nanocomposite was separated by means of centrifugation 
at 13,200 RPM for 20 min and re-dispersion in H2O dist.
UV–Vis spectroscopy measurements were recorded 
with a Shimadzu UV-1800™ instrument. UV–Vis spectra 
were recorded for the AgNP, IgG, IgG–CF and AgNP–
IgG–CF samples in the 800–200 nm range, with a spec-
tral resolution of 0.5  nm. The OriginLab® 7.0 software 
was used for normalization of the registered spectra.
Dynamic light scattering (DLS) data was registered 
on a Zetasizer—Nano S90 instrument (Malvern Instru-
ments, Westborough, UK) at 20  °C and a 90° diffraction 
angle; a refractive index of 0.20 and a material absorption 
of 3.980 were considered.
Universal attenuated total reflectance Fourier trans-
form infra-red spectroscopy (UATR-FT-IR) measure-
ments were performed on a Perkin-Elmer Spectrum 
Two® instrument equipped with a diamond ATR stage. 
All registered spectra were processed with the aid of the 
Spectrum 10™ software.
Atomic force microscopy (AFM) was conducted of a 
Workshop TT-AFM® instrument (AFMWorkshop, CA, 
USA), equipped with ACTA-SS cantilevers (AppNano, 
CA, USA) operated in vibrating mode. The samples were 
deposited on a mica substrate with the aid of a KLM® 
SCC spin-coater. The registered data was processed with 
the aid of the Gwyddion® 2.36 software.
Conclusions
Monodisperse IgG-folinate functionalized silver nano-
particles with sizes around 39  nm were obtained. UV–
Vis and UATR-FT-IR spectroscopies were employed to 
confirm the successful functionalization of the silver 
nanoparticles. AFM and DLS measurements gave infor-
mation about the size and shape of the nanoparticles 
prior and after the passivation with IgG. Immunoglobulin 
G formed a monolayer around the nanoparticles with the 
binding site seemingly in the Fc domain, leaving the two 
Fab regions available for antigen binding. To our knowl-
edge, this is the first report of an IgG-folinate function-
alized AgNP bionanostructure developed for biological 
applications. Further investigations are being carried out 
regarding the AgNP–IgG–CF interactions in biological 
systems.
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